Greetings From the Editor of Clinical Thyroidology

Abstract

Clinical ThyroidologyVol. 34, No. 1 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyAngela M. LeungAngela M. LeungSearch for more papers by this authorPublished Online:4 Jan 2022https://doi.org/10.1089/ct.2022;34.4-5AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail DEAR COLLEAGUES,Happy new year! We're pleased to ring in the new year with this first issue of 2022. I'm particularly thrilled to introduce the newest members of our editorial board, toward the mission of continually providing a diverse set of perspectives, areas of focus, and commentaries to the literature we review. Please join me in welcoming our newest experts to the Clinical Thyroidology editorial board: Dr. Sara Ahmadi, Brigham and Women's Hospital, U.S.A.Dr. Takashi Akamizu, Kuma Hospital, Japan.Dr. Lindsay Bischoff, Vanderbilt University, U.S.A.Dr. Kenneth Burman, Georgetown University, U.S.A.Dr. Mayumi Endo, University of Washington, U.S.A.Dr. Natalia Genere, Washington University, U.S.A.Dr. Giorgio Grani, Sapienza University of Rome, ItalyDr. Allen Ho, Cedars Sinai Medical Center, U.S.A.Dr. Joana Klubo-Gwiezdzinska, National Institutes of Health, U.S.A.Dr. Anupam Kotwal, University of Nebraska Medical Center, U.S.ADr. Elizabeth McAninch, Stanford University Medical Center, U.S.A.Dr. Alex Tessnow, University of Texas Southwestern Medical Center, U.S.A.In this issue, we begin with Dr. Gary Francis reviewing a study that examines the associations between thyroid disorders in adolescence and incident type 2 diabetes mellitus in adulthood. Is there good news for those waiting for a thyroid hormone treatment that can maintain sustained serum T3 concentrations? Dr. Elizabeth McAninch discusses a Phase 1 clinical trial of PZL, a new compound that shows promise to do just that. Addressing the topic of hyperthyroidism, Drs. Matthew Balcerek and Donald McLeod review a meta-analysis assessing the associations between radioactive iodine use and incident cancer risks, while Dr. Lilah Morris-Wiseman shares her perspective on a patient survey study surrounding quality of life and thyroid-specific symptoms before and after thyroidectomy for Graves’ disease.Dr. Natalia Genere summarizes a study assessing the very common clinical scenario of incidentally finding a thyroid nodule on FDG PET CT scanning — should these incidentalomas be standardly evaluated for a potential biopsy? On a similar topic, Dr. Giorgio Grani provides his perspectives on a recent meta-analysis assessing the appropriateness of thyroid ultrasonography use in routine clinical practice.Epidemiologic considerations of the rising incidence of thyroid cancer is assessed in a study discussed by Drs. Reem ElSheikh and Spyridoula Maraka. Drs. Omar El Kawkgi and Juan Brito discuss a survey study assessing the demographic characteristics of patients with thyroid cancer and their clinicians who advise their diagnostic and treatment recommendations. The mechanisms of resistance from lenvatinib combined with anti-PD-1 combination therapy are explored in a recent study covered by Dr. Benjamin Gigliotti. From a surgical perspective, Drs. Amanda Bastien and Allen Ho provide their insights on how anatomic variations of the recurrent laryngeal nerve may be an important consideration during thyroid surgery.Finally, we are thrilled to feature the top-scoring abstracts presented at the 2021 Annual Meeting of the American Thyroid Association throughout the journal this year. Our first abstract this year is authored by Drs. Malik Faheem, Yasaman Motlaghzadeh, Ivana Jankovic, and Chrysoula Dosiou, who describe a case series of 3 patients who all experienced silent thyroiditis following receipt of an mRNA vaccine for SARS-CoV-2. I urge you all to read their description of these interesting patients and proposed possible mechanisms for this entity.We invite our readers to join us through our social media channels. Through the following, we discuss content featured in each month's issue and other issues related to hot topics in the clinical thyroid literature:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgAlso, note that most of the material covered in Clinical Thyroidology is also translated into shorter lay summaries in our sister journal, Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), that is edited by Dr. Alan Farwell and his team each month. The summaries in CTFP may be of use to patients and the public who are interested in reading more about recently published studies in the clinical thyroid literature.I hope that each issue provides helpful reviews, commentaries, editorials, and perspectives regarding how best to treat patients with thyroid disease. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at clinicalthyroidology@thyroid.org.Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 34Issue 1Jan 2022 InformationCopyright 2022 American Thyroid Association, Inc.To cite this article:Angela M. Leung.Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology.Jan 2022.4-5.http://doi.org/10.1089/ct.2022;34.4-5Published in Volume: 34 Issue 1: January 4, 2022PDF download